Published in Mediators Inflamm on October 23, 2014
Estradiol Priming Improves Gonadotrope Sensitivity and Pro-Inflammatory Cytokines in Obese Women. J Clin Endocrinol Metab (2015) 0.80
Inflammatory regulation of steroid sulfatase: A novel mechanism to control estrogen homeostasis and inflammation in chronic liver disease. J Hepatol (2015) 0.80
The effects of oestrogens and their receptors on cardiometabolic health. Nat Rev Endocrinol (2017) 0.75
Lower body mass index is associated with a higher risk of giant cell arteritis: a systematic review and meta-analysis. Ann Transl Med (2015) 0.75
Oxyresveratrol Is a Phytoestrogen Exerting Anti-inflammatory Effects Through NF-κB and Estrogen Receptor Signaling. Inflammation (2017) 0.75
Protective regulation of the ACE2/ACE gene expression by estrogen in human atrial tissue from elderly men. Exp Biol Med (Maywood) (2017) 0.75
Roles of G protein-coupled estrogen receptor GPER in metabolic regulation. J Steroid Biochem Mol Biol (2017) 0.75
Sex Steroid Hormones Regulate Leptin Transcript Accumulation and Protein Secretion in 3T3-L1 Cells. Sci Rep (2017) 0.75
Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest (2003) 41.22
Inflammation and metabolic disorders. Nature (2006) 33.33
Alternative activation of macrophages. Nat Rev Immunol (2003) 27.53
Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial. JAMA (2004) 23.69
The metabolic syndrome. Lancet (2005) 19.47
The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol (2004) 19.38
Inflammation, stress, and diabetes. J Clin Invest (2005) 17.11
Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes (2007) 14.12
Adipose tissue as an endocrine organ. J Clin Endocrinol Metab (2004) 11.94
Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans. J Lipid Res (2005) 11.88
Origin and physiological roles of inflammation. Nature (2008) 11.68
Cloning of a novel receptor expressed in rat prostate and ovary. Proc Natl Acad Sci U S A (1996) 10.94
Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta. Endocrinology (1997) 10.08
Inflammatory mechanisms in obesity. Annu Rev Immunol (2011) 9.83
A transmembrane intracellular estrogen receptor mediates rapid cell signaling. Science (2005) 9.80
Adipokines in inflammation and metabolic disease. Nat Rev Immunol (2011) 8.92
Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes. Nat Rev Mol Cell Biol (2008) 8.43
Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome. Endocr Rev (2000) 8.15
From endoplasmic-reticulum stress to the inflammatory response. Nature (2008) 7.17
Inflammatory links between obesity and metabolic disease. J Clin Invest (2011) 6.73
Adipocyte death, adipose tissue remodeling, and obesity complications. Diabetes (2007) 6.11
Increased inflammatory properties of adipose tissue macrophages recruited during diet-induced obesity. Diabetes (2007) 6.08
Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex. Diabetologia (2003) 5.91
Reduction of macrophage infiltration and chemoattractant gene expression changes in white adipose tissue of morbidly obese subjects after surgery-induced weight loss. Diabetes (2005) 5.68
The cellular and signaling networks linking the immune system and metabolism in disease. Nat Med (2012) 5.63
The many faces of CREB. Trends Neurosci (2005) 5.58
Estrogen-induced activation of Erk-1 and Erk-2 requires the G protein-coupled receptor homolog, GPR30, and occurs via trans-activation of the epidermal growth factor receptor through release of HB-EGF. Mol Endocrinol (2000) 5.53
Increased adipose tissue in male and female estrogen receptor-alpha knockout mice. Proc Natl Acad Sci U S A (2000) 5.47
Free fatty acids in obesity and type 2 diabetes: defining their role in the development of insulin resistance and beta-cell dysfunction. Eur J Clin Invest (2002) 5.31
Comparison of the release of adipokines by adipose tissue, adipose tissue matrix, and adipocytes from visceral and subcutaneous abdominal adipose tissues of obese humans. Endocrinology (2004) 4.67
Phenotypic switching of adipose tissue macrophages with obesity is generated by spatiotemporal differences in macrophage subtypes. Diabetes (2008) 4.56
A high-fat meal induces low-grade endotoxemia: evidence of a novel mechanism of postprandial inflammation. Am J Clin Nutr (2007) 4.34
Mechanisms of obesity-associated insulin resistance: many choices on the menu. Genes Dev (2007) 4.23
The complex role of estrogens in inflammation. Endocr Rev (2007) 4.07
Thematic review series: Adipocyte Biology. Adipocyte stress: the endoplasmic reticulum and metabolic disease. J Lipid Res (2007) 3.96
Estrogen deficiency and bone loss: an inflammatory tale. J Clin Invest (2006) 3.45
Gender differences in insulin resistance, body composition, and energy balance. Gend Med (2009) 3.19
Emerging role of adipose tissue hypoxia in obesity and insulin resistance. Int J Obes (Lond) (2008) 3.17
Increased infiltration of macrophages in omental adipose tissue is associated with marked hepatic lesions in morbid human obesity. Diabetes (2006) 3.06
Transcriptional control of energy homeostasis by the estrogen-related receptors. Endocr Rev (2008) 3.05
Obesity, regional fat distribution, and syndrome X in obese black versus white adolescents: race differential in diabetogenic and atherogenic risk factors. J Clin Endocrinol Metab (2003) 3.01
Aromatase-deficient (ArKO) mice have a phenotype of increased adiposity. Proc Natl Acad Sci U S A (2000) 2.83
The perfect storm: obesity, adipocyte dysfunction, and metabolic consequences. Clin Chem (2008) 2.72
Repression of the interleukin-6 promoter by estrogen receptor is mediated by NF-kappa B and C/EBP beta. Mol Cell Biol (1995) 2.71
Sources of estrogen and their importance. J Steroid Biochem Mol Biol (2003) 2.54
Aromatase--a brief overview. Annu Rev Physiol (2002) 2.49
Regulation of aromatase expression in estrogen-responsive breast and uterine disease: from bench to treatment. Pharmacol Rev (2005) 2.44
Separation of human adipocytes by size: hypertrophic fat cells display distinct gene expression. FASEB J (2006) 2.41
Estrogen action via the cAMP signaling pathway: stimulation of adenylate cyclase and cAMP-regulated gene transcription. Proc Natl Acad Sci U S A (1994) 2.41
Estrogen regulation of adiposity and fuel partitioning. Evidence of genomic and non-genomic regulation of lipogenic and oxidative pathways. J Biol Chem (2005) 2.33
Activation of the novel estrogen receptor G protein-coupled receptor 30 (GPR30) at the plasma membrane. Endocrinology (2007) 2.29
Thematic review series: adipocyte biology. Adipose tissue function and plasticity orchestrate nutritional adaptation. J Lipid Res (2007) 2.25
Insulin sensitivity, insulin secretion, and abdominal fat: the Insulin Resistance Atherosclerosis Study (IRAS) Family Study. Diabetes (2003) 2.22
Hypoxia regulates macrophage functions in inflammation. J Immunol (2005) 2.19
Chronic inflammation in obesity and the metabolic syndrome. Mediators Inflamm (2010) 2.18
Impaired preadipocyte differentiation in human abdominal obesity: role of Wnt, tumor necrosis factor-alpha, and inflammation. Diabetes (2009) 2.11
Visceral adiposity and the risk of impaired glucose tolerance: a prospective study among Japanese Americans. Diabetes Care (2003) 2.10
Deletion of the G protein-coupled receptor 30 impairs glucose tolerance, reduces bone growth, increases blood pressure, and eliminates estradiol-stimulated insulin release in female mice. Endocrinology (2008) 2.09
Estrogens protect against high-fat diet-induced insulin resistance and glucose intolerance in mice. Endocrinology (2009) 2.05
Estrogen and mechanisms of vascular protection. Arterioscler Thromb Vasc Biol (2009) 2.01
Pathogenic potential of adipose tissue and metabolic consequences of adipocyte hypertrophy and increased visceral adiposity. Expert Rev Cardiovasc Ther (2008) 1.95
Obesity and disturbed lipoprotein profile in estrogen receptor-alpha-deficient male mice. Biochem Biophys Res Commun (2000) 1.94
The role of estrogens in control of energy balance and glucose homeostasis. Endocr Rev (2013) 1.93
Role of estrogens in adipocyte development and function. Exp Biol Med (Maywood) (2004) 1.93
Inflammatory lipid mediators in adipocyte function and obesity. Nat Rev Endocrinol (2010) 1.87
ERRalpha: a metabolic function for the oldest orphan. Trends Endocrinol Metab (2008) 1.83
Immunometabolism: an emerging frontier. Nat Rev Immunol (2011) 1.82
GPR30 contributes to estrogen-induced thymic atrophy. Mol Endocrinol (2007) 1.78
Meta-analysis: effect of hormone-replacement therapy on components of the metabolic syndrome in postmenopausal women. Diabetes Obes Metab (2006) 1.72
Steroid sulfatase: molecular biology, regulation, and inhibition. Endocr Rev (2004) 1.69
Impaired oxidative metabolism and inflammation are associated with insulin resistance in ERalpha-deficient mice. Am J Physiol Endocrinol Metab (2009) 1.69
Response-specific and ligand dose-dependent modulation of estrogen receptor (ER) alpha activity by ERbeta in the uterus. Endocrinology (2003) 1.66
Association of polymorphisms in the estrogen receptor alpha gene with body fat distribution. Int J Obes Relat Metab Disord (2003) 1.64
Inflammation and impaired adipogenesis in hypertrophic obesity in man. Am J Physiol Endocrinol Metab (2009) 1.63
The atherogenic lipoprotein profile associated with obesity and insulin resistance is largely attributable to intra-abdominal fat. Diabetes (2003) 1.62
Deficits in E2-dependent control of feeding, weight gain, and cholecystokinin satiation in ER-alpha null mice. Endocrinology (2001) 1.61
Production of plasminogen activator inhibitor 1 by human adipose tissue: possible link between visceral fat accumulation and vascular disease. Diabetes (1997) 1.60
Estrogen--the good, the bad, and the unexpected. Endocr Rev (2005) 1.57
Estrogen receptor impairs interleukin-6 expression by preventing protein binding on the NF-kappaB site. Nucleic Acids Res (1997) 1.56
The correlation between adiposity and adiponectin, tumor necrosis factor alpha, interleukin-6 and high sensitivity C-reactive protein levels. Is adipocyte size associated with inflammation in adults? J Endocrinol Invest (2007) 1.56
Importance of extranuclear estrogen receptor-alpha and membrane G protein-coupled estrogen receptor in pancreatic islet survival. Diabetes (2009) 1.53
The diversity of sex steroid action: regulation of metabolism by estrogen signaling. J Endocrinol (2011) 1.52
Myeloid-specific estrogen receptor alpha deficiency impairs metabolic homeostasis and accelerates atherosclerotic lesion development. Proc Natl Acad Sci U S A (2011) 1.52
Thematic review series: Adipocyte Biology. Lipodystrophies: windows on adipose biology and metabolism. J Lipid Res (2007) 1.52
Increased visceral fat and serum levels of triglyceride are associated with insulin resistance in Japanese metabolically obese, normal weight subjects with normal glucose tolerance. Diabetes Care (2003) 1.49
Do regional differences in adipocyte biology provide new pathophysiological insights? Trends Pharmacol Sci (2003) 1.49
Estrogen prevents the lipopolysaccharide-induced inflammatory response in microglia. J Neurosci (2001) 1.42
Orphan nuclear receptor Errγ induces C-reactive protein gene expression through induction of ER-bound Bzip transmembrane transcription factor CREBH. PLoS One (2014) 1.42
Estrogen and androgen receptors: regulators of fuel homeostasis and emerging targets for diabetes and obesity. Trends Endocrinol Metab (2010) 1.41
Mechanisms of antidiabetogenic and body weight-lowering effects of estrogen in high-fat diet-fed mice. Am J Physiol Endocrinol Metab (2008) 1.40
Aromatase: biologic relevance of tissue-specific expression. Semin Reprod Med (2004) 1.38
Oestrogens and insulin secretion. Diabetologia (2005) 1.38
Estradiol down-regulates LPS-induced cytokine production and NFkB activation in murine macrophages. Am J Reprod Immunol (1997) 1.38
Differential susceptibility to obesity between male, female and ovariectomized female mice. Nutr J (2009) 1.36
The metabolic syndrome in obese postmenopausal women: relationship to body composition, visceral fat, and inflammation. J Clin Endocrinol Metab (2004) 1.35
Altered expression of fatty acid-metabolizing enzymes in aromatase-deficient mice. J Clin Invest (2000) 1.35
DHEA and the intracrine formation of androgens and estrogens in peripheral target tissues: its role during aging. Steroids (1998) 1.35
Aromatase expression in health and disease. Recent Prog Horm Res (1997) 1.35
Estrogen modulates abdominal adiposity and protects female mice from obesity and impaired glucose tolerance. Eur J Nutr (2011) 1.34